CAAR ruled that multi-functional PCR instruments cannot be treated as spectrometers where optical detection is only one part ...

HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.

The series of thermoelectric coolers (TECs) is engineered specifically for demanding PCR (Polymerase Chain Reaction) testing applications, delivering high reliability, precise temperature control, and ...

The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana ...

New trials highlight Pathlight’s performance in the neoadjuvant triple-negative breast cancer (TNBC) settingMORRISVILLE, N.C.--(BUSINESS WIRE)--#BreastCancer--SAGA Diagnostics®, a pioneer in ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of ...

DM had rejected the claim citing absence of a valid COVID-19 test report and relying on two doctors’ statements disputing the antigen-positive slip ...

*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...

The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

The Sandiganbayan has upheld its earlier resolution allowing the withdrawal of the Pharmally cases for review and possible refiling by the Office of the Ombudsman.